emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension. [PDF]
, 2013 The aim of this study was to develop a measure of the impact of pulmonary hypertension (PH) on health-related quality of life (HRQoL) as there is a need for a short, validated instrument that can be used in routine clinical practice.
Armstrong, I. +7 more
core +2 more sources
Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years
Journal of the European Academy of Dermatology and Venereology, EarlyView.The current study found no evidence of cumulative increased safety risks with upadacitinib 15 or 30 mg for up to 6 years and over 9000 patient‐years of safety data in adults and adolescents. There were low rates of adjudicated major adverse cardiovascular events, adjudicated thromboembolic events and malignancies. Abstract Background Atopic dermatitis (
Christopher G. Bunick +13 more
wiley +1 more source
Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension [PDF]
, 2017 Pulmonary arterial hypertension (PAH) describes a group of conditions with a common hemodynamic phenotype of increased pulmonary artery pressure, driven by progressive remodeling of small pulmonary arteries, leading to right heart failure and death ...
Lawrie, A., Thompson, A.A.R.
core +1 more source
Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study [PDF]
, 2017 Michael Halank +10 more
openalex +1 more source
Journal of Internal Medicine, EarlyView.Abstract Background The long‐term risk across severity strata of people infected with SARS‐CoV‐2 has not yet been comprehensively described. Methods Using nationwide registries, all COVID‐19 cases in Sweden with <2 vaccine doses, with and without initial hospitalization (February 1, 2020 to June 30, 2022), were identified and matched with non‐COVID ...
Martin Lindgren +10 more
wiley +1 more source
The role of endothelin-1 in pulmonary arterial hypertension. [PDF]
, 2014 Pulmonary arterial hypertension (PAH) is a rare but debilitating disease, which if left untreated rapidly progresses to right ventricular failure and eventually death. In the quest to understand the pathogenesis of this disease differences in the profile,
Chester, AH, Yacoub, MH
core +1 more source
Preoperative balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension led to successful anesthetic management for total hysterectomy under general anesthesia: a case report [PDF]
, 2020 Tomoko Ota +3 more
openalex +1 more source
Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension
Chest, 2023 Jenny Z. Yang +3 more
semanticscholar +1 more source
The pathophysiology of chronic thromboembolic pulmonary hypertension
European Respiratory Review, 2017 Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, progressive pulmonary vascular disease that is usually a consequence of prior acute pulmonary embolism.
G. Simonneau +3 more
semanticscholar +1 more source